BioScrip Inc (NASDAQ:BIOS)

BioScrip, Inc. provides pharmacy and home health services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivers access to prescription medications and home health services. Its services are designed to improve clinical outcomes with chronic and acute healthcare conditions. The company operates through two segments: Infusion/Home Health Services and Pharmacy Services. The Infusion/Home Health Services segment consists of its home infusion business combined with the home infusion and home health service businesses. Its infusion services include home infusion therapy, respiratory therapy and durable medical equipment and dispensing and administering of infusion-based drugs, which typically require additional nursing and clinical management services, equipment to administer the correct dosage and patient training designed to improve patient outcomes. This segment's home health services include the provision of skilled nursing and therapy visits, private duty nursing services, rehabilitation services, hospice and medical social services to patients primarily in their home. The Pharmacy Services segment consists of its traditional and specialty pharmacy mail operations, community pharmacies, prescription discount card programs and integrated pharmacy benefit management services. Its services are designed to offer patients and other customers' the delivery of traditional and specialty pharmacy products and services and also includes care management programs customized to each patient's care plan in coordination with the patient's physician. BioScrip was founded in 1996 and is headquartered in Elmsford, NY.